Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 41, Issue 9 (Sep 2003)

Issues

Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS)

Susan Manley
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.182

Abstract

Haemoglobin A1c (HbA1c) is the pre-eminent factor for quantifying the risk of complications in patients with diabetes and for monitoring glycaemia. Intervention to lower blood glucose in the two landmark clinical trials, the UK Prospective Diabetes Study (UKPDS) and the Diabetes Control and Complications Trial (DCCT), led to a reduction in the microvascular complications of diabetes.

Glycaemic status could be compared in the UKPDS and DCCT as the Bio-Rad Diamat HPLC analyser, as used in the DCCT, was introduced in 1989 for measurement of HbA1c in the UKPDS, after liaison with the DCCT. Results from other methods used for measurement of glycated haemoglobin during the UKPDS were aligned to this method. The Bio-Rad Diamat analyser in the central laboratory for the UKPDS, reference range 4.5–6.2% HbA1c, was certified as comparable to the DCCT by the National Glycohemoglobin Standardization Program in 1998.

A median difference in HbA1c of 0.9% was maintained over 10 years between the intensively and conventionally treated groups in the UKPDS (7.0% vs. 7.9% HbA1c) despite HbA1c increasing over time. Clinical care was transferred to general practitioners after the end of the main glucose control study for post-study monitoring. Over the first 3 years of post-study monitoring, HbA1c rose slightly in the previously intensively treated group with no appreciable increase in the conventional group, due to intensification of therapy.

At near-normal HbA1c, <6%, the updated mean value chosen to reflect glycaemic exposure throughout the UKPDS, the incidence of myocardial infarction was 2–3 times that of microvascular disease, with similar incidences for both complications at >10% updated mean HbA1c. Relationships between the risk of complications of type 2 diabetes and updated mean HbA1c had no observable thresholds. The UKPDS risk engine derived from the UKPDS database calculates coronary heart disease risk using HbA1c as a continuous variable and could now replace the Framingham equations for patients with type 2 diabetes.

About the article

Published Online: 2005-06-01

Published in Print: 2003-09-16


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.182.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Eckhard Salzsieder, Petra Augstein, Lutz Vogt, Klaus-Dieter Kohnert, Peter Heinke, Ernst-Joachim Freyse, Abdel Azim Ahmed, Zakia Metwali, Iman Salman, and Omer Attef
Journal of Diabetes Science and Technology, 2007, Volume 1, Number 4, Page 511
[2]
Jochen Sieber, Frank Flacke, Bonnie Dumais, Casey C. Peters, Erin B. Mallery, and Liz Taylor
Journal of Diabetes Science and Technology, 2016, Volume 10, Number 1, Page 67
[3]
Chen-Ling Huang, Usman Iqbal, Phung-Anh Nguyen, Zih-Fang Chen, Daniel L. Clinciu, Yi-Hsin Elsa Hsu, Chung-Huei Hsu, Wen-Shan Jian, and Salomon Amar
PLoS ONE, 2014, Volume 9, Number 8, Page e104263
[4]
Alejandro Dain, Gaston Repossi, Gustavo T. Diaz-Gerevini, Jairam Vanamala, Undurti N. Das, and Aldo R. Eynard
Lipids in Health and Disease, 2016, Volume 15, Number 1
[5]
Yoshiharu Horie, Naoyuki Hayashi, Klaus Dugi, and Masahiro Takeuchi
Trials, 2009, Volume 10, Number 1
[6]
E. Salzsieder, L. Vogt, K.-D. Kohnert, P. Heinke, and P. Augstein
IFAC Proceedings Volumes, 2009, Volume 42, Number 12, Page 43
[7]
Abdulghani H. Al-Saeed, Maria I. Constantino, Lynda Molyneaux, Mario D’Souza, Franziska Limacher-Gisler, Connie Luo, Ted Wu, Stephen M. Twigg, Dennis K. Yue, and Jencia Wong
Diabetes Care, 2016, Volume 39, Number 5, Page 823
[8]
Stephen J. Hattan, Kenneth C. Parker, Marvin L. Vestal, Jane Y. Yang, David A. Herold, and Mark W. Duncan
Journal of The American Society for Mass Spectrometry, 2016, Volume 27, Number 3, Page 532
[9]
Maria Salinas, Maite Lopez-Garrigós, Francisco Pomares, Jose Manuel Ruiz-Palomar, Ana Santo-Quiles, Luis López-Penabad, Alberto Asencio, and Joaquin Uris
Laboratory Medicine, 2012, Volume 43, Number 2, Page 1.3
[10]
D. Vistisen, S. Colagiuri, and K. Borch-Johnsen
Diabetes Care, 2009, Volume 32, Number 3, Page 397
[11]
M. I. Constantino, L. Molyneaux, F. Limacher-Gisler, A. Al-Saeed, C. Luo, T. Wu, S. M. Twigg, D. K. Yue, and J. Wong
Diabetes Care, 2013, Volume 36, Number 12, Page 3863
[12]
D. Simmons and T. Hlaing
Diabetic Medicine, 2014, Volume 31, Number 11, Page 1387
[13]
Susan E. Manley, Laura J. Hikin, Rachel A. Round, Peter W. Manning, Stephen D. Luzio, Gareth J. Dunseath, Peter G. Nightingale, Irene M. Stratton, Robert Cramb, Kenneth A. Sikaris, Stephen C.L. Gough, and Jonathan Webber
Diabetes Research and Clinical Practice, 2014, Volume 105, Number 3, Page 364
[14]
Maria Salinas, Maite López-Garrigós, Joaquín Uris, and Carlos Leiva-Salinas
Clinical Biochemistry, 2014, Volume 47, Number 12, Page 1104
[15]
S. van Dieren, A. P. Kengne, J. Chalmers, J. W. J. Beulens, T. M. E. Davis, G. Fulcher, S. R. Heller, A. Patel, S. Colagiuri, P. Hamet, G. Mancia, M. Marre, B. Neal, B. Williams, L. M. Peelen, Y. T. van der Schouw, M. Woodward, and S. Zoungas
Diabetes, Obesity and Metabolism, 2014, Volume 16, Number 5, Page 426
[16]
Boris P. Kovatchev, Frank Flacke, Jochen Sieber, and Marc D. Breton
Diabetes Technology & Therapeutics, 2014, Volume 16, Number 5, Page 303
[17]
Soraya Soulimane, Dominique Simon, William H. Herman, Celine Lange, Crystal M. Y. Lee, Stephen Colagiuri, Jonathan E. Shaw, Paul Z. Zimmet, Dianna Magliano, Sandra R. G. Ferreira, Yanghu Dong, Lei Zhang, Torben Jorgensen, Jaakko Tuomilehto, Viswanathan Mohan, Dirk L. Christensen, Lydia Kaduka, Jacqueline M. Dekker, Giel Nijpels, Coen D. A. Stehouwer, Olivier Lantieri, Wilfred Y. Fujimoto, Donna L. Leonetti, Marguerite J. McNeely, Knut Borch-Johnsen, Edward J. Boyko, Dorte Vistisen, and Beverley Balkau
Diabetologia, 2014, Volume 57, Number 1, Page 30
[18]
Liyong Yang, Ximei Shen, Sunjie Yan, Xin Yuan, Juanjuan Lu, and Wenfeng Wei
Diabetes Research and Clinical Practice, 2013, Volume 101, Number 1, Page 28
[19]
[20]
Barbara Strasser
Annals of the New York Academy of Sciences, 2013, Volume 1281, Number 1, Page 141
[21]
Xiao-Wu Chen, Yuan Ming Di, Jian Zhang, Zhi-Wei Zhou, Chun Guang Li, and Shu-Feng Zhou
The Scientific World Journal, 2012, Volume 2012, Page 1
[22]
E Adamska, M Waszczeniuk, J Gościk, A Golonko, J Wilk, J Pliszka, K Maliszewska, D Lipińska, R Milewski, A Wasilewska, A Citko, A Nikołajuk, L Ostrowska, A Krętowski, and M Górska
Advances in Medical Sciences, 2012, Volume 57, Number 2, Page 296
[23]
M. Rahman, R. K. Simmons, S. H. Hennings, N. J. Wareham, and S. J. Griffin
Diabetologia, 2012, Volume 55, Number 6, Page 1651
[24]
[25]
María Salinas, Maite López-Garrigós, Arturo Carratala, Cristina Aguado, Julián Díaz, Mario Ortuño, Enrique Rodriguez-Borja, Martín Yago, Virtudes Chinchilla, Goizane Marcaida, Ángel Esteban, Begoña Laíz, Marcos Guaita, Miguel Ángel Lorente, Francisco Pomares, and Joaquín Uris
Endocrinología y Nutrición, 2011, Volume 58, Number 5, Page 219
[26]
María Salinas, Maite López-Garrigós, Arturo Carratala, Cristina Aguado, Julián Díaz, Mario Ortuño, Enrique Rodriguez-Borja, Martín Yago, Virtudes Chinchilla, Goizane Marcaida, Ángel Esteban, Begoña Laíz, Marcos Guaita, Miguel Ángel Lorente, Francisco Pomares, and Joaquín Uris
Endocrinología y Nutrición (English Edition), 2011, Volume 58, Number 5, Page 219
[28]
Jennifer Gutierrez and Judith A. Long
Diabetes Research and Clinical Practice, 2011, Volume 92, Number 3, Page 342
[29]
Pedro Conthe, Manuel Mata, Domingo Orozco, Francisco Pajuelo, Carmen Sofía Barreto, Silvia Fernández Anaya, and Ramón Gomis
Diabetes Research and Clinical Practice, 2011, Volume 91, Number 1, Page 108
[30]
Erh-Jung Huang, Wei-Wen Kuo, Yuh-Jyuan Chen, Ter-Hsin Chen, Mu-Hsin Chang, Min-Chi Lu, Bor-Show Tzang, Hsi-Hsien Hsu, Chih-Yang Huang, and Shin-Da Lee
Clinica Chimica Acta, 2006, Volume 366, Number 1-2, Page 293
[31]
Hao Zhang, Jing Wei, Rong Xue, Jin-Dan Wu, Wei Zhao, Zi-Zheng Wang, Shu-Kui Wang, Zheng-Xian Zhou, Dan-Qing Song, Yue-Ming Wang, Huai-Ning Pan, Wei-Jia Kong, and Jian-Dong Jiang
Metabolism, 2010, Volume 59, Number 2, Page 285
[32]
E. Salzsieder, L. Vogt, K.-D. Kohnert, P. Heinke, and P. Augstein
Computer Methods and Programs in Biomedicine, 2011, Volume 102, Number 2, Page 206
[33]
Ben F. Hurley, Erik D. Hanson, and Andrew K. Sheaff
Sports Medicine, 2011, Volume 41, Number 4, Page 289
[34]
Allison Hedley Dodd, Margaret S. Colby, Kristina S. Boye, Cheryl Fahlman, Sunny Kim, and Ronette R. Briefel
Current Medical Research and Opinion, 2009, Volume 25, Number 7, Page 1605
[35]
Antje Steveling, Henry Völzke, Matthias Nauck, and Henri Wallaschofski
LaboratoriumsMedizin, 2009, Volume 33, Number 1, Page 11
[36]
Antje Steveling, Henry Völzke, Matthias Nauck, and Henri Wallaschofski
LaboratoriumsMedizin, 2009, Volume 33, Number 1, Page -
[37]
[38]
Tim Snijders, Lex B. Verdijk, Dominique Hansen, Paul Dendale, and Luc J.C. van Loon
Muscle & Nerve, 2011, Volume 43, Number 3, Page 393
[39]
Muhammad F. Dawwas, James D. Lewsey, Christopher J. Watson, and Alexander E. Gimson
Transplantation, 2009, Volume 88, Number 3, Page 402
[40]
Berhane Seyum, Goitom Mebrahtu, Abdulmumini Usman, Jacob Mufunda, Beyene Tewolde, Solomon Haile, Andrew Kosia, and Ermias Negassi
Acta Diabetologica, 2010, Volume 47, Number 1, Page 23
[41]
D. Hansen, P. Dendale, R. A. M. Jonkers, M. Beelen, R. J. F. Manders, L. Corluy, A. Mullens, J. Berger, R. Meeusen, and L. J. C. van Loon
Diabetologia, 2009, Volume 52, Number 9, Page 1789
[42]
Massimo Chello, Cristiano Spadaccio, Mario Lusini, Elvio Covino, Carla Blarzino, Federico De Marco, Fabio Di Domenico, and Raffaella Coccia
Diabetes/Metabolism Research and Reviews, 2009, Volume 25, Number 5, Page 420
[43]
Speranza Rubattu
High Blood Pressure & Cardiovascular Prevention, 2007, Volume 14, Number 3, Page 119
[44]
P. D. Home
Diabetic Medicine, 2008, Volume 25, Page 2
[45]
Bruce Frier, Pearl Yang, and Albert W. Taylor
European Review of Aging and Physical Activity, 2006, Volume 3, Number 2, Page 63
[46]
Lotte Steuten, Bert Vrijhoef, Hans Severens, Frits van Merode, and Cor Spreeuwenberg
International Journal of Technology Assessment in Health Care, 2006, Volume 22, Number 01, Page 47
[47]
Michael Maris, Lut Overbergh, Wannes D'Hertog, and Chantal Mathieu
Expert Opinion on Medical Diagnostics, 2008, Volume 2, Number 3, Page 277
[48]
Kathleen H. Berecek and David Calhoun
Current Hypertension Reports, 2005, Volume 7, Number 3, Page 204
[49]
Domenic A. Sica
The Journal of Clinical Hypertension, 2005, Volume 7, Number 1, Page 59
[50]
N. Ahmed and P. J. Thornalley
Diabetes, Obesity and Metabolism, 2007, Volume 9, Number 3, Page 233
[51]
Cloud P. Paweletz, Matthew C. Wiener, Jeffrey R. Sachs, Roger Meurer, Margaret S. Wu, Kenney K. Wong, Nathan A. Yates, and Ronald C. Hendrickson
PROTEOMICS, 2006, Volume 6, Number 7, Page 2101
[52]
[53]
N. Ahmed, R. Babaei-Jadidi, S. K. Howell, P. J. Beisswenger, and P. J. Thornalley
Diabetologia, 2005, Volume 48, Number 8, Page 1590

Comments (0)

Please log in or register to comment.
Log in